Speaker
Description
The COVID-19 pandemic that started in 2020 coincided with large changes in the epidemiology of many other infectious diseases. These changes were likely driven by the large-scale behavioural changes in populations around the world. This talk summarises empirical and modelling investigations on the way that the COVID-19 pandemic (and associated interventions) affected other infectiou diseases.
References
Gaythorpe KA, Abbas K, Huber J, Karachaliou A, Thakkar N, Woodruff K, Li X, Echeverria-Londono S; VIMC Working Group on COVID-19 Impact on Vaccine Preventable Disease; Ferrari M, Jackson ML, McCarthy K, Perkins TA, Trotter C, Jit M. Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries. Elife. 2021 Jun 24;10:e67023. doi: 10.7554/eLife.67023. PMID: 34165077; PMCID: PMC8263060.
Koltai M, Krauer F, Hodgson D, van Leeuwen E, Treskova-Schwarzbach M, Jit M, Flasche S. Determinants of RSV epidemiology following suppression through pandemic contact restrictions. Epidemics. 2022 Sep;40:100614. doi: 10.1016/j.epidem.2022.100614. Epub 2022 Jul 21. PMID: 35901639; PMCID: PMC9301974.
Chen Y, Li N, Lourenço J, Wang L, Cazelles B, Dong L, Li B, Liu Y, Jit M, Bosse NI, Abbott S, Velayudhan R, Wilder-Smith A, Tian H, Brady OJ; CMMID COVID-19 Working Group. Measuring the effects of COVID-19-related disruption on dengue transmission in southeast Asia and Latin America: a statistical modelling study. Lancet Infect Dis. 2022 May;22(5):657-667. doi: 10.1016/S1473-3099(22)00025-1. Epub 2022 Mar 2. PMID: 35247320; PMCID: PMC8890758.
| Keywords | infectious diseases, modelling, COVID-19 |
|---|
